Sonoco Products
SON
47.74
-0.28
-0.58%
Sonoco Products
US · SON
#2161 by market cap
Listed 1970
47.74
-0.28
-0.58%
Live - 5344 symbols - heartbeat 238s ago
· 2026-10-08 09:10
Pre-market
48.00
+0.54%
After-hours
47.74
0.00%
- Market cap
- 4.72B
- P/E (TTM)i
- 7.59
- P/Bi
- 1.32
- EPSi
- 10.07
- Div yieldi
- 4.46%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on SON?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.70, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +41.72% YoY
Margins
- Gross margin
- 20.94%
- Operating margin
- 9.47%
- Net margin
- 13.34%
Key ratios & quality
- Enterprise valuei
- 8.67B
- PEG ratioi
- 0.26
- Altman Z-Scorei
- 1.70
PEG uses trailing P/E against the 3-year net income growth rate (29.07%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.39B | 5.37B | 5.24B | 5.59B | 5.86B | 5.44B | 5.31B | 7.52B |
| Gross profit | 1.04B | 1.06B | 1.05B | 1.06B | 1.23B | 1.20B | 1.14B | 1.57B |
| Selling & admin expenses | 563.31M | 530.87M | 528.44M | 558.18M | 609.58M | 644.54M | 723.83M | 862.18M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 477.70M | 526.96M | 517.90M | 503.73M | 615.74M | 558.03M | 415.40M | 712.23M |
| Pretax profit | 378.53M | 380.77M | 255.59M | -160.98M | 459.93M | 489.03M | 63.49M | 765.10M |
| Tax | 75.01M | 93.27M | 53.03M | -67.43M | 95.73M | 119.73M | 5.51M | 183.59M |
| Net profit | 314.74M | 292.67M | 207.24M | -82.71M | 466.98M | 475.90M | 163.94M | 1.00B |
| Basic EPS | 3 | 3 | 2 | -1 | 5 | 5 | 2 | 10 |
| Diluted EPS | 3.10 | 2.88 | 2.05 | -0.86 | 4.72 | 4.80 | 1.65 | 10.07 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.71B | 1.91B | 2.13B | 1.77B | 1.68B | 1.89B |
| Gross profit | 353.69M | 406.28M | 467.35M | 347.10M | 345.63M | 392.38M |
| Selling & admin expenses | 209.06M | 218.78M | 220.97M | 213.38M | 201.54M | 200.25M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 144.62M | 187.50M | 246.39M | 133.72M | 144.09M | 192.13M |
| Pretax profit | 68.54M | 105.88M | 127.76M | 462.92M | 76.45M | 142.31M |
| Tax | 21.15M | 39.50M | 7.72M | 115.22M | 9.51M | 39.55M |
| Net profit | 54.49M | 493.20M | 123.07M | 332.63M | 67.63M | 105.02M |
| Basic EPS | 1 | 5 | 1 | 3 | 1 | 1 |
| Diluted EPS | 0.55 | 4.96 | 1.23 | 3.33 | 0.68 | 1.05 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.52B | 1.52B | 1.83B | 1.66B | 2.36B | 2.05B | 3.18B | 2.65B |
| Cash & ST investments | 120.39M | 145.28M | 564.85M | 170.98M | 227.44M | 138.90M | 431.01M | 378.40M |
| Inventory | 493.76M | 503.81M | 450.69M | 562.11M | 1.10B | 603.65M | 1.02B | 1.12B |
| Total assets | 4.58B | 5.13B | 5.28B | 5.07B | 7.05B | 7.19B | 12.51B | 11.16B |
| Total current liabilities | 1.08B | 1.40B | 1.51B | 1.53B | 1.74B | 1.17B | 4.04B | 2.53B |
| Short-term debt | 195.45M | 488.23M | 455.78M | 411.56M | 502.44M | 38.93M | 2.05B | 537.95M |
| Long-term debt | 1.19B | 1.19B | 1.24B | 1.20B | 2.72B | 3.00B | 4.99B | 3.79B |
| Total liabilities | 2,811,187,000.00 | 3,310,584,000.00 | 3,366,731,000.00 | 3,223,694,000.00 | 4,980,143,000.00 | 4,760,122,000.00 | 10,221,577,000.00 | 7,530,502,000.00 |
| Total equity | 1.77B | 1.82B | 1.91B | 1.85B | 2.07B | 2.43B | 2.29B | 3.63B |
| Retained earnings | 2.19B | 2.30B | 2.34B | 2.07B | 2.35B | 2.62B | 2.58B | 3.38B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.17B | 3.04B | 3.16B | 2.65B | 2.74B | 2.79B |
| Cash & ST investments | 181.83M | 329.80M | 244.86M | 378.40M | 224.48M | 168.65M |
| Inventory | 1.14B | 1.28B | 1.16B | 1.12B | 1.22B | 1.26B |
| Total assets | 12.68B | 11.97B | 11.72B | 11.16B | 11.07B | 10.97B |
| Total current liabilities | 3.99B | 2.42B | 3.42B | 2.53B | 2.85B | 2.80B |
| Short-term debt | 2.15B | 436.88M | 1.37B | 537.95M | 1.20B | 968.75M |
| Long-term debt | 4.98B | 4.99B | 3.79B | 3.79B | 3.49B | 3.48B |
| Total liabilities | 10,218,661,000.00 | 8,719,591,000.00 | 8,396,608,000.00 | 7,530,502,000.00 | 7,483,652,000.00 | 7,375,560,000.00 |
| Total equity | 2.46B | 3.25B | 3.32B | 3.63B | 3.59B | 3.60B |
| Retained earnings | 2.59B | 3.03B | 3.10B | 3.38B | 3.39B | 3.44B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 589.90M | 425.85M | 705.62M | 298.67M | 509.05M | 882.92M | 833.85M | 689.78M |
| Depreciation & amortization | 236.25M | 239.14M | 261.29M | 245.18M | 308.82M | 340.99M | 374.86M | 519.36M |
| Free cash flow | 397.32M | 229.92M | 511.49M | 42.65M | 180.28M | 519.84M | 440.61M | 345.76M |
| Dividends paid | -161.43M | -170.25M | -172.63M | -178.62M | -187.09M | -197.42M | -203.49M | -208.11M |
| Stock buybacks / issuance | -14.56M | -9.61M | -8.48M | -218.09M | -4.55M | -10.62M | -9.25M | -10.93M |
| Ending cash balance | 120.39M | 145.28M | 564.85M | 170.98M | 227.44M | 151.94M | 443.06M | 378.40M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -208.09M | 193.44M | 291.55M | 412.89M | -367.93M | 300.62M |
| Depreciation & amortization | 121.49M | 129.48M | 131.66M | 136.73M | 125.03M | 131.10M |
| Free cash flow | -300.75M | 98.62M | 225.62M | 322.27M | -430.01M | 236.94M |
| Dividends paid | -51.29M | -52.27M | -52.21M | -52.34M | -52.40M | -53.39M |
| Stock buybacks / issuance | -10.57M | -3.00K | -4.00K | -350.00K | -6.95M | -57.00K |
| Ending cash balance | 191.72M | 329.80M | 245.87M | 378.40M | 224.48M | 168.65M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.09 | 16.38 | 11.21 | -4.57 | 23.90 | 21.16 | 6.98 | 34.08 |
| ROA %i | 6.86 | 6.01 | 3.99 | -1.65 | 7.69 | 6.67 | 1.66 | 8.47 |
| ROIC %i | 11.44 | 9.83 | 6.96 | -1.12 | 11.79 | 10.09 | 3.86 | 13.11 |
| 5-year avg ROE %i | 15.72 | 16.16 | 15.06 | 10.39 | 13.00 | 13.61 | 11.73 | 16.31 |
| EBIT margin %i | 8.19 | 8.33 | 6.31 | -1.73 | 9.28 | 11.08 | 4.45 | 13.28 |
| FCF / sales %i | 7.37 | 4.28 | 9.77 | 0.76 | 2.49 | 7.67 | 8.31 | 4.60 |
| Current ratioi | 1.40 | 1.08 | 1.21 | 1.09 | 1.35 | 1.76 | 0.79 | 1.05 |
| Quick ratioi | 0.90 | 0.68 | 0.88 | 0.67 | 0.68 | 0.76 | 0.38 | 0.55 |
| Debt / assetsi | 30.22 | 37.75 | 37.18 | 36.36 | 49.25 | 44.91 | 58.35 | 41.12 |
| LT debt / equityi | 67.63 | 80.28 | 79.31 | 78.00 | 143.81 | 131.61 | 230.86 | 112.13 |
| Interest coveragei | 6.99 | 6.70 | 4.41 | -1.52 | 6.62 | 5.50 | 1.37 | 4.28 |
| Revenue CAGR (3Y) %i | 2.79 | 3.96 | 1.31 | 1.22 | 2.92 | 1.28 | -1.73 | 8.67 |
| Net income CAGR (3Y) %i | 7.82 | 0.62 | 5.77 | -- | 16.93 | 31.80 | -- | 29.07 |
| FCF CAGR (3Y) %i | 15.09 | 2.75 | 47.52 | -52.47 | -7.79 | 0.54 | 117.79 | 24.24 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.29 | 19.60 | 21.71 | 34.08 | 33.78 | 18.42 |
| ROA %i | 1.54 | 5.81 | 6.05 | 8.47 | 8.56 | 5.47 |
| ROIC %i | 3.64 | 9.41 | 9.81 | 13.11 | 12.75 | 8.95 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.05 | 5.65 | 6.22 | 13.28 | 13.29 | 13.57 |
| FCF / sales %i | 1.05 | 2.25 | 4.19 | 4.60 | 2.89 | 4.76 |
| Current ratioi | 0.80 | 1.25 | 0.92 | 1.05 | 0.96 | 0.99 |
| Quick ratioi | 0.34 | 0.66 | 0.45 | 0.55 | 0.47 | 0.49 |
| Debt / assetsi | 58.39 | 47.55 | 46.10 | 41.12 | 44.75 | 42.94 |
| LT debt / equityi | 214.70 | 162.41 | 122.02 | 112.13 | 105.12 | 104.54 |
| Interest coveragei | 1.45 | 1.53 | 1.88 | 4.28 | 4.48 | 4.99 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Consumer Packaging is the largest reported line at 66.02% of revenue, across 3 reported segments.
- Industrial Paper Packaging follows at 35.80%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Consumer Packaging66.02%
Industrial Paper Packaging35.80%
Quote time 2026-10-08 09:10:49 · For reference only, not investment advice and not tailored to your situation.